Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
34.96
-0.42 (-1.19%)
At close: May 29, 2026, 4:00 PM EDT
35.04
+0.08 (0.23%)
After-hours: May 29, 2026, 7:47 PM EDT
Cogent Biosciences Employees
Cogent Biosciences had 258 employees as of December 31, 2025. The number of employees increased by 53 or 25.85% compared to the previous year.
Employees
258
Change (1Y)
53
Growth (1Y)
25.85%
Revenue / Employee
n/a
Profits / Employee
-$1,373,267
Market Cap
5.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 258 | 53 | 25.85% |
| Dec 31, 2024 | 205 | 41 | 25.00% |
| Dec 31, 2023 | 164 | 26 | 18.84% |
| Dec 31, 2022 | 138 | 61 | 79.22% |
| Sep 30, 2022 | 121 | 44 | 57.14% |
| Dec 31, 2021 | 77 | 62 | 413.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Celcuity | 155 |
| Protagonist Therapeutics | 131 |
COGT News
- 7 hours ago - Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 days ago - Cogent Biosciences announces FDA acceptance of bezuclastinib NDA - TheFly
- 2 days ago - Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST - GlobeNewsWire
- 3 days ago - Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 18 days ago - Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress - GlobeNewsWire
- 23 days ago - Cogent Biosciences price target raised to $55 from $52 at H.C. Wainwright - TheFly
- 25 days ago - Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results - GlobeNewsWire
- 25 days ago - Cogent Biosciences Earnings release: Q1 2026 - Filings